J.B. Chemicals & Pharmaceuticals Lt (Delisted) share news and announcements

BSE: 506943Pharmaceuticals & Biotechnology

Last traded ₹2,408.90 on 16 Jul 2026

Delisted on 12 Oct 2026.

J.B. Chemicals & Pharmaceuticals Lt share news and announcements

1,922 announcements, routine notices left out, newest first. Page 6 of 39.

Apr 2025
- 18 Apr · Updates
  ANDA Approval by US FDA (opens in a new tab)
- 18 Apr
  ANDA Approval by US FDA (opens in a new tab)
- 11 Apr · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
  Disclosure submitted to exchange on April 2, 2025 and exchange email dated April 11, 2025 (opens in a new tab)
- 11 Apr · Noting Of Cautionary Letter Received From The Exchanges
  Disclosure submitted to the exchange on April 2, 2025 and exchange email dated April 11, 2025 (opens in a new tab)
- 4 Apr · Disclosure
  Tau Investment Holdings Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Apr · Updates
  Noting of Cautionary letter received from the Exchanges (opens in a new tab)
- 2 Apr · General Updates
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (opens in a new tab)
- 1 Apr · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for abrdn Asia Ltd (opens in a new tab)
Mar 2025
- 29 Mar · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Cautionary Letter (opens in a new tab)
- 29 Mar · General Updates
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 28 Mar · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investment Holdings Pte Ltd & PACs (opens in a new tab)
- 18 Mar · Disclosure
  Allotment of Equity shares on exercise of stock options pursuant to Employee Stock Option Scheme (opens in a new tab)
- 18 Mar · Disclosure
  Allotment of 1700 Shares. (opens in a new tab)
- 14 Mar
  USFDA inspection of Company's API manufacturing facility - D9 at Panoli, Gujarat (opens in a new tab)
- 14 Mar · Updates
  USFDA inspection of Company s API manufacturing facility D9 at Panoli, Gujarat (opens in a new tab)
- 8 Mar
  USFDA inspection of Company's manufacturing facility - T20 at Panoli, Gujarat (opens in a new tab)
- 8 Mar · Updates
  USFDA inspection of Company s manufacturing facility T20 at Panoli, Gujarat (opens in a new tab)
- 5 Mar
  DJSI (Dow Jones Sustainable Index) ESG Score release (opens in a new tab)
- 5 Mar · Updates
  DJSI (Dow Jones Sustainable Index) ESG Score release (opens in a new tab)
Feb 2025
- 28 Feb · General Updates
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (opens in a new tab)
- 28 Feb · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order (opens in a new tab)
- 27 Feb · Disclosure
  Allotment of 69180 Shares. (opens in a new tab)
- 27 Feb · Disclosure
  Allotment of equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme (opens in a new tab)
- 19 Feb · Analysts
  Intimation of schedule of Analysts/ Institutional Investors meet (opens in a new tab)
- 19 Feb · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order (opens in a new tab)
- 19 Feb · General Updates
  Intimation of schedule of Analysts/Institutional investors meet (opens in a new tab)
- 19 Feb · General Updates
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (opens in a new tab)
- 4 Feb · Results
  Integrated filing (Financial) for the quarter and nine months ended December 31, 2024 (opens in a new tab)
- 4 Feb · Results
  Integrated filing (Financial) for the quarter and nine months ended December 31, 2024 (opens in a new tab)
- 4 Feb · Updates
  Board comments on fine levied by the Exchange for delayed compliance (opens in a new tab)
- 4 Feb
  Board comments on fine levied by the Exchange for delayed compliance (opens in a new tab)
- 4 Feb · Corporate action
  Record date for the purpose of Dividend is 08-Feb-2025. (opens in a new tab)
- 4 Feb · Dividend
  Board of Directors at its meeting held on February 04, 2025, declared Interim Dividend of 8.50 per equity share. (opens in a new tab)
- 4 Feb · Corporate action
  Intimation of record date (opens in a new tab)
- 4 Feb · Dividend
  Declaration of interim dividend of Rs. 8.5 per equity share of Fv Re. 1 each for the FY 2024-25 (opens in a new tab)
- 4 Feb · Business
  Press release dated February 04, 2025, titled "Press Release". (opens in a new tab)
- 4 Feb · Results
  Financial results for the period ended December 31, 2024. (opens in a new tab)
- 4 Feb · Business
  Press Release (opens in a new tab)
- 4 Feb · Results
  Unaudited Financial Results for the quarter ended on December 31, 2024 (opens in a new tab)
- 4 Feb · General Updates
  Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 (opens in a new tab)
- 4 Feb · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Receipt of Order (opens in a new tab)
Jan 2025
- 24 Jan · Analysts
  Investors/Analysts call with Management (opens in a new tab)
- 24 Jan · Analysts
  Schedule of meet (opens in a new tab)
- 24 Jan · Board meeting
  To consider and approve the unaudited financial results for the period ended December 31, 2024 and to consider interim dividend, if any, for the financial year 2024-25 (opens in a new tab)
- 24 Jan · Board meeting
  J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve (i) unaudited .... (opens in a new tab)
- 24 Jan · Disclosure
  Allotment of 57600 Shares. (opens in a new tab)
- 24 Jan · Disclosure
  Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme (opens in a new tab)
- 16 Jan · Updates
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (opens in a new tab)
- 16 Jan · Updates
  Presentation (opens in a new tab)
- 16 Jan
  Presentation (opens in a new tab)